Notably, the notions on experimental plasticity (animal models, in vitro and ex vivo ) may find a plausible target for plasticity studies in humans within the transcranial magnetic stimulation (TMS) technique
Low Risk of Hypoglycemia Unlike other diabetes medications that can cause low blood sugar, GLP-1 injections have a lower risk of hypoglycemia because they increase insulin release in a glucose-dependent manner
A.MahmoudN
Treatments are tailored to restore hormonal balance, enhancing energy, mood, and overall vitality
Reference link (FDA label PDF): Other narrow therapeutic index medicines (where small changes in absorption can matter) may warrant extra attention depending on the patient (examples often discussed for the GLP-1 class include warfarin or digoxinmonitoring decisions should be individualized)
The drug, which was originally developed at Karuna Therapeutics, began its development journey as an investigational treatment at Eli Lilly for Alzheimers disease, where its effects on the psychotic symptoms of the disease where discovered